Cargando…
Prophylactic intravitreal 5-fluorouracil and heparin to prevent proliferative vitreoretinopathy in high-risk patients with retinal detachment: study protocol for a randomized controlled trial
BACKGROUND: Proliferative vitreoretinopathy (PVR) is the major cause for postoperative failure after vitreo-retinal surgery for primary rhegmatogenous retinal detachment (RRD). Adjunct pharmaceutical therapy was found to be ineffective once PVR is established. Preliminary data suggest that preventio...
Autores principales: | Schaub, Friederike, Hoerster, Robert, Schiller, Petra, Felsch, Moritz, Kraus, Daria, Zarrouk, Marouan, Kirchhof, Bernd, Fauser, Sascha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048849/ https://www.ncbi.nlm.nih.gov/pubmed/30012187 http://dx.doi.org/10.1186/s13063-018-2761-x |
Ejemplares similares
-
Combined 5-Fluorouracil and Low Molecular Weight Heparin for the Prevention of Postoperative Proliferative Vitreoretinopathy in Patients With Retinal Detachment: A Meta-Analysis
por: Chen, Chen, et al.
Publicado: (2021) -
Intravitreal methotrexate infusion for proliferative vitreoretinopathy
por: Sadaka, Ama, et al.
Publicado: (2016) -
Intravitreal methotrexate for the treatment of proliferative vitreoretinopathy
por: Benner, Jeffrey David, et al.
Publicado: (2019) -
Use of Intravitreal Methotrexate Infusion in Complicated Retinal Detachment for Prevention of Proliferative Vitreoretinopathy in a Pilot Study
por: Jahangir, Sana, et al.
Publicado: (2021) -
Vitrectomy with Silicone Oil Tamponade and Single-Dose Intravitreal Methotrexate for Recurrent Retinal Detachment with Proliferative Vitreoretinopathy
por: Babel, Adrian, et al.
Publicado: (2022)